Kailera Therapeutics CTO Nur Nicholson files initial beneficial ownership statement
KLRA•Initial beneficial ownership filing
Kailera Therapeutics named Nur Nicholson as chief technology officer in an initial SEC ownership filing dated Aug. 31, 2026.
